The NFL and NFL Players Association (NFLPA) have jointly announced an investigation into the Philadelphia Eagles' handling of quarterback Jalen Hurts' blood clot diagnosis, with no set timeline for completion.
Hurts was placed on injured reserve on Oct. 19 after doctors discovered deep vein thrombosis and bilateral pulmonary emboli, requiring him to begin a blood thinner regimen. The Eagles stated he underwent an ultrasound one day before a Week 5 game in London, which revealed a blood clot in his calf. Despite this, he played in the game, completing 21-of-40 passes for 220 yards, one touchdown, and no interceptions. Four days later, the team announced Hurts would miss the remainder of the regular season.
The investigation’s scope includes a review of the Eagles’ medical screening procedures and the timing of Hurts’ diagnosis. The NFL and NFLPA released a joint statement confirming the review, while the league’s chief medical officer, Dr. Allen Sills, publicly expressed ‘complete confidence’ in the Eagles’ medical staff.
NFLPA’s role in the review
The NFLPA has exercised its right under the Collective Bargaining Agreement to independently assess the situation, signaling skepticism about the league’s initial assessment. NFL commissioner Roger Goodell stated the union’s involvement was welcome, emphasizing transparency as part of the process.
Eagles’ response and lack of clarity
The Eagles have not provided detailed public explanations regarding the medical decisions leading to Hurts’ diagnosis or the timing of his treatment. Coach Nick Sirianni declined to elaborate beyond stating he is not a medical professional. Team medical staff and general manager Howie Roseman have also not addressed the matter publicly.
Medical timeline and implications
Hurts’ return timeline remains uncertain, as he cannot play until the clots are resolved and he is no longer on blood thinners. The Eagles, now on a four-game losing streak, will look to end their skid when they host the Dallas Cowboys in Week 7. Backup quarterback Tanner McKee has started in Hurts’ absence, throwing for 215 yards and one touchdown in a Week 6 loss to the Carolina Panthers.
League and union statements
The NFL and NFLPA’s joint statement did not specify further details but confirmed the investigation’s initiation. The league’s defense of the Eagles’ medical staff contrasts with the NFLPA’s proactive review, highlighting differing perspectives on accountability within the organization.
Background: Hurts’ diagnosis and impact
Hurts, a three-time Pro Bowl selection, suffered the blood clot discovery after the Eagles’ Week 5 loss in London. The team’s decision to allow him to play despite the ultrasound findings has since drawn scrutiny, particularly given the subsequent discovery of additional clots in his lungs. The investigation aims to clarify whether standard medical protocols were followed and whether any preventable factors contributed to the delayed full diagnosis.